On the other hand, Seedhouse et al. identified, in a large cohort of trial samples, a lower FOXO1 expression level in FLT3-ITDs AML cells (p < 0.001), whereas they do not find statistically significant differences in FOXO3 and FOXO4 expression [47]. This evidence concerns the gene FLT3 and acute myeloid leukemia.